Suppr超能文献

口腔癌前病变:从病理学角度看。

Oral premalignant lesions: from the pathological viewpoint.

机构信息

Department of Pathology, Saitama Cancer Center, 818 Komuro, Ina-machi, Saitama 362-0806, Japan.

出版信息

Int J Clin Oncol. 2011 Feb;16(1):15-26. doi: 10.1007/s10147-010-0169-z. Epub 2011 Jan 14.

Abstract

Under the widely used World Health Organization (WHO) classification for the pathological diagnosis of oral premalignant lesions, dysplasia, which is graded as mild, moderate or severe, and carcinoma in situ (CIS), which is a non-invasive carcinoma, are classified as precursor lesions of oral squamous cell carcinoma. Since the first edition (Wahi et al. International histological classification of tumours no. 4, WHO, Geneva, 1971), the criterion for CIS--that all epithelial layers are replaced by atypical cells--has remained unchanged. However, this dysplasia-carcinoma sequence theory was introduced from the viewpoint of pathological changes in the uterine cervix: in contrast, almost all premalignant lesions and CIS of the oral mucosa show superficial maturation and differentiation. Based on this recognition, the squamous intraepithelial neoplasia (SIN) classification and Ljubljana classification were included in WHO's latest edition published in 2005. Although the WHO classification is commonly used in Japan, recent developments in oral oncology have promoted modifications of the classification used in this country. In 2005, the Working Group of the Japan Society for Oral Tumours advocated iodine staining and proposed a modified SIN system, and in 2007, the Working Committee of the Japanese Society for Oral Pathology (JSOP) reported a new CIS (JSOP) definition that included differentiated-type CIS. In 2010, based on these studies, a new entity--oral intraepithelial neoplasia (OIN)--was included in the first edition of General Rules for Clinical and Pathological Studies on Oral Cancer. In this review, we focus on the OIN/CIS (JSOP) new classification of premalignant lesions in oral mucosa, which further advances the concept of SIN.

摘要

在世界卫生组织(WHO)广泛使用的口腔癌前病变病理学诊断分类中,将轻度、中度或重度异型增生和原位癌(CIS)归类为口腔鳞状细胞癌的前驱病变。自第一版(Wahi 等人,《国际肿瘤组织学分类》第 4 版,WHO,日内瓦,1971 年)以来,CIS 的标准——即所有上皮层均被非典型细胞取代——一直没有改变。然而,这种异型增生-癌序列理论是从子宫颈的病理变化角度引入的:相比之下,口腔黏膜的几乎所有癌前病变和 CIS 都表现出表面成熟和分化。基于这一认识,2005 年出版的最新版 WHO 分类中纳入了鳞状上皮内肿瘤(SIN)分类和卢布尔雅那分类。虽然 WHO 分类在日本被广泛使用,但口腔肿瘤学的最新进展促进了该国使用的分类的修改。2005 年,日本口腔肿瘤学会工作组提倡碘染色并提出了改良的 SIN 系统,2007 年,日本口腔病理学会(JSOP)工作组报告了一种新的 CIS(JSOP)定义,其中包括分化型 CIS。2010 年,基于这些研究,一种新的实体——口腔上皮内瘤变(OIN)——被纳入《口腔癌临床与病理研究通用规则》第一版。在这篇综述中,我们重点介绍口腔黏膜癌前病变的 OIN/CIS(JSOP)新分类,这进一步推进了 SIN 的概念。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验